Amy L. Burroughs is a director of Tenaya Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Terns Pharmaceuticals, Inc.
5 Mar 24
3
Terns Pharmaceuticals, Inc.
15 Feb 24
4
Tenaya Therapeutics, Inc.
12 Jun 23
4
DiaMedica Therapeutics Inc.
3 Jan 23
4
Tenaya Therapeutics, Inc.
7 Dec 22
3
Tenaya Therapeutics, Inc.
7 Dec 22
4
DiaMedica Therapeutics Inc.
2 Jun 22
4
DiaMedica Therapeutics Inc.
3 Jan 22
4
DiaMedica Therapeutics Inc.
17 Aug 21
4
DiaMedica Therapeutics Inc.
16 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | TERN Terns Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 7.31 | 1,250,000 | 9.14 mm | 1,250,000 |
1 Mar 24 | TERN Terns Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 150,000 | 0.00 | 150,000 |
9 Jun 23 | TNYA Tenaya Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.12 | 14,766 | 105.13 k | 14,766 |